Vera Therapeutics

VERA THERAPEUTICS INC

VERAMARK TECHS INC

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Merger,And,Acquisition,Business,Corporate,Cooperation,Company,Concept.,Ma,Partnership

News

Health Care

Markets

Media

AACT

INSM

KRYS

MDGL

NFLX

PSKY

TRIP

VERA

MNTA

Goldman Sachs destacó seis acciones de EE. UU. con probabilidad de ser adquiridas en 2025, en medio de un auge de fusiones y adquisiciones.

6 acciones de EE. UU. con alto potencial de adquisición en 2025 según Goldman Sachs

Vera Therapeutics, Inc. - Class A Common Stock

Vera Therapeutics Inc

Verastem Inc

Veralto Corp

VERANO HLDGS CORP by Verano Holdings Corp.

Verano Holdings Corp

Veracyte Inc

Veradigm Inc

Vera Bradley Inc

VERALLIA,COURBEVOIE by VERALLIA, COURBEVOIE

Verallia

Verasity

Press Releases

General

Vera Therapeutics Announces Atacicept Achieved 46% Proteinuria Reduction in ORIGIN Phase 3 Trial in Adults with IgA Nephropathy

Financing

Vera Therapeutics Announces Refinancing of Existing Oxford Debt Facility, Providing up to $500 Million of Term Loans

Vera Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Earnings

Vera Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vera Therapeutics to Participate at Upcoming Investor Conferences

Aurinia Pharmaceuticals Inc - Common Shares

Aurinia Pharmaceuticals

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharma

Biohaven

Celcuity

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics

Cogent Biosciences

Denali Therapeutics

Dyne Therapeutics

89bio

Galapagos NV - American Depositary Shares

Galapagos

ImmunityBio

IDEAYA Biosciences

Immunocore Holdings plc - American Depositary Shares

Immunocore Holdings

Janux Therapeutics

MannKind

NuCana

Arcus Biosciences

Recursion Pharmaceuticals, Inc. - Class A Common Stock

Recursion Pharmaceuticals

Syndax Pharmaceuticals, Inc. - Common Stock

Syndax Pharmaceuticals

Sarepta Therapeutics, Inc. - Common Stock

Sarepta Therapeutics

Stoke Therapeutics

Travere Therapeutics, Inc. - Common Stock

Travere Therapeutics

Twist Bioscience Corporation - Common Stock

Twist Bioscience

Vericel

Viridian Therapeutics, Inc. - Common Stock

Viridian Therapeutics

JP Morgan

Scotiabank

HC Wainwright & Co.

Wedbush

Cantor Fitzgerald

Comments

Vera Therapeutics

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL